Laboratory research material

CJC-1295 With DAC 10mg

£34.99

⚠ Important – Acetic Acid Water (AA Water) Handling Notice

Previous product handling guidance identified Acetic Acid Water (AA Water) for this material. The manufacturer-specific solvent requirement is awaiting verification.

Do not assume that bacteriostatic water is interchangeable. Follow a validated laboratory protocol.

For laboratory research only. Not for human use.

CJC-1295 With DAC 10mg research peptide (also written CJC1295) is a GHRH analogue carrying a Drug Affinity Complex (DAC) that binds serum albumin, giving it a much longer half-life than non-DAC analogues in published human research (Teichman et al., 2006). A Janoshik report is published for a tested batch. Same working-day UK dispatch on in-stock orders before 3pm (Mon–Fri). For in-vitro research use only.

Research guides: With DAC vs Without DAC · GHRH analogues vs GHRPs

  • Same working-day dispatch on in-stock orders before 3pm, Mon–Fri
  • Royal Mail Tracked 24, free UK delivery on orders of £50 or more
  • Certificates of analysis published on our CoA page
  • Laboratory research use only; 18+ to purchase
Key Features

Form: Lyophilized peptide powder

  • Quantity: 1 vial (10mg)
  • Intended Use: Research purposes only

Safety Information: Not intended for human or veterinary use. Use appropriate laboratory safety procedures when handling.

CJC-1295 WITH DAC 10mg should only be used in laboratory settings by qualified personnel.

Ensure all experimental procedures comply with local and institutional regulations.

This peptide is supplied for research and scientific study purposes only.

CJC-1295 (With DAC) 10 mg:
View Janoshik report #125385 (tested sample: CJC1295 with DAC 10mg)

This report covers one tested sample. It does not establish that current stock comes from the same batch.

Product Details

CJC-1295 With DAC 10mg Research Peptide UK

CJC-1295 With DAC 10mg is a synthetic analogue of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) that binds serum albumin. This gives it a longer half-life than non-DAC GHRH analogues: published human clinical research by Teichman et al. (2006) reported an estimated half-life of approximately 5.8–8.1 days in that study.

At a glance

  • Quantity10mg
  • FormatLyophilized peptide powder
  • Intended useResearch use only

Full Research Information

Like other GHRH analogues, CJC-1295 With DAC acts as an agonist at the GHRH receptor (GHRHR) on anterior pituitary somatotroph cells, initiating the cAMP/PKA signalling cascade associated with GH secretion in published research models.

CJC-1295 With DAC 10mg can be studied alongside Ipamorelin 5mg or Ipamorelin 10mg. These two compounds target mechanistically distinct receptors: CJC-1295 with DAC targets GHRHR, while ipamorelin targets GHS-R1a (the ghrelin receptor). Both increase GH release, and combined GHRH and GHRP stimulation can interact, so in the same experimental system they are not independent variables and combined arms need appropriate controls.

For researchers comparing GHRH analogue structures, this compound can be studied alongside CJC-1295 Without DAC 10mg (shorter-acting non-DAC analogue), Sermorelin 2mg (unmodified GRF(1-29) sequence), and Tesamorelin 5mg (full 44-amino acid GHRH sequence). For a structural and pharmacokinetic comparison of both variants, see our CJC-1295 With DAC vs Without DAC comparison guide.

Evidence status: in two randomised, placebo-controlled trials in healthy adults, CJC-1295 with DAC raised mean GH and IGF-1 for several days after a single dose, with an estimated half-life of 5.8 to 8.1 days and no serious adverse reactions reported (Teichman et al., J Clin Endocrinol Metab, 2006). It has not been approved as a medicine. These data do not describe or verify the research material supplied here.

A CJC-1295 With DAC 10mg batch has been independently tested by Janoshik. Its published Certificate of Analysis reports measured content and purity for that batch and is available for independent verification. LC-MS identity data is not separately reported on the published certificate.

Storage and handling requirements for CJC-1295 With DAC are being confirmed with the manufacturer. Please contact ASCEND for the information held for the current stock.

WADA Status

Prohibited at all times under WADA and UKAD regulations.

Disclaimer

For in-vitro laboratory research only. Not for human consumption. Not an MHRA-licensed medicine.

More Research Materials

Other laboratory research materials supplied by Ascend Peptides UK.

Acetic Acid 10ml research solvent vial

Acetic Acid 10ml

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

Bacteriostatic Water 10ml research solvent vial

Bacteriostatic Water 10ml

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

MOTS-C 40mg UK research peptide vial

MOTS-C 40mg

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML

MOTS-C 10mg UK research peptide vial

MOTS-C 10mg

Spend £75 and get a FREE BACTERIOSTATIC WATER 10ML